tiprankstipranks
Skye Bioscience (SKYE)
NASDAQ:SKYE
US Market
Want to see SKYE full AI Analyst Report?

Skye Bioscience (SKYE) Stock Forecast & Price Target

1,007 Followers
See the Price Targets and Ratings of:

SKYE Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Skye
Bioscience
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SKYE Stock 12 Month Forecast

There Are No Analyst Ratings for SKYE In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

SKYE Financial Forecast

SKYE Earnings Forecast

Next quarter’s earnings estimate for SKYE is -$1.14 with a range of -$1.19 to -$1.12. The previous quarter’s EPS was -$2.16. SKYE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year SKYE has Performed in-line its overall industry.
Next quarter’s earnings estimate for SKYE is -$1.14 with a range of -$1.19 to -$1.12. The previous quarter’s EPS was -$2.16. SKYE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year SKYE has Performed in-line its overall industry.
No data currently available

SKYE Sales Forecast

Next quarter’s sales forecast for SKYE is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. SKYE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year SKYE has Performed in-line its overall industry.
Next quarter’s sales forecast for SKYE is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. SKYE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year SKYE has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on SKYE
H.C. Wainwright
H.C. Wainwright
$20
Buy
890.10%
Upside
Reiterated
05/21/26
Analyst Reiterates Buy on Skye Bioscience, Maintains $20 Price Target on Positive Nimacimab Safety and Efficacy Data
Piper Sandler Analyst forecast on SKYE
Piper Sandler
Piper Sandler
$13$6
Buy
197.03%
Upside
Assigned
05/12/26
Skye Bioscience price target lowered to $6 from $13 at Piper SandlerSkye Bioscience price target lowered to $6 from $13 at Piper Sandler
William Blair Analyst forecast on SKYE
William Blair
William Blair
Buy
Reiterated
05/12/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Coherus Biosciences (NASDAQ: CHRS), Moderna (NASDAQ: MRNA) and Skye Bioscience (NASDAQ: SKYE)
Craig-Hallum Analyst forecast on SKYE
Craig-Hallum
Craig-Hallum
Hold
Reiterated
03/11/26
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF), BioNTech SE (NASDAQ: BNTX) and Skye Bioscience (NASDAQ: SKYE)
Cantor Fitzgerald Analyst forecast on SKYE
Cantor Fitzgerald
Cantor Fitzgerald
$2
Hold
-0.99%
Downside
Reiterated
03/10/26
Skye Bioscience (SKYE) Receives a Hold from Cantor Fitzgerald
Citizens JMP Analyst forecast on SKYE
Citizens JMP
Citizens JMP
$16$4
Buy
98.02%
Upside
Reiterated
10/06/25
Citizens JMP Remains a Buy on Skye Bioscience (SKYE)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on SKYE
H.C. Wainwright
H.C. Wainwright
$20
Buy
890.10%
Upside
Reiterated
05/21/26
Analyst Reiterates Buy on Skye Bioscience, Maintains $20 Price Target on Positive Nimacimab Safety and Efficacy Data
Piper Sandler Analyst forecast on SKYE
Piper Sandler
Piper Sandler
$13$6
Buy
197.03%
Upside
Assigned
05/12/26
Skye Bioscience price target lowered to $6 from $13 at Piper SandlerSkye Bioscience price target lowered to $6 from $13 at Piper Sandler
William Blair Analyst forecast on SKYE
William Blair
William Blair
Buy
Reiterated
05/12/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Coherus Biosciences (NASDAQ: CHRS), Moderna (NASDAQ: MRNA) and Skye Bioscience (NASDAQ: SKYE)
Craig-Hallum Analyst forecast on SKYE
Craig-Hallum
Craig-Hallum
Hold
Reiterated
03/11/26
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF), BioNTech SE (NASDAQ: BNTX) and Skye Bioscience (NASDAQ: SKYE)
Cantor Fitzgerald Analyst forecast on SKYE
Cantor Fitzgerald
Cantor Fitzgerald
$2
Hold
-0.99%
Downside
Reiterated
03/10/26
Skye Bioscience (SKYE) Receives a Hold from Cantor Fitzgerald
Citizens JMP Analyst forecast on SKYE
Citizens JMP
Citizens JMP
$16$4
Buy
98.02%
Upside
Reiterated
10/06/25
Citizens JMP Remains a Buy on Skye Bioscience (SKYE)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BTSGBrightSpring Health Services, Inc.
GPCRStructure Therapeutics, Inc. Sponsored ADR
BLTEBelite Bio, Inc. ADR
AMLXAmylyx Pharmaceuticals Inc
IMMXImmix Biopharma
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Skye Bioscience

3 Months
Andy HsiehWilliam Blair
Success Rate
3/11 ratings generated profit
27%
Average Return
-5.52%
Copying Andy Hsieh's trades and holding each position for 3 Months would result in 27.27% of your transactions generating a profit, with an average return of -5.52% per trade.
1 Year
Edward TenthoffPiper Sandler
Success Rate
0/13 ratings generated profit
0%
Average Return
-65.58%
Copying Edward Tenthoff's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -65.58% per trade.
2 Years
Andy HsiehWilliam Blair
Success Rate
0/11 ratings generated profit
0%
Average Return
-85.18%
Copying Andy Hsieh's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -85.18% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SKYE Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
4
4
1
1
0
Buy
2
3
2
2
0
Hold
2
2
0
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
8
9
3
4
1
In the current month, SKYE has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. SKYE average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

SKYE Stock Forecast FAQ

What is SKYE’s average 12-month price target, according to analysts?
Currently, no data Available
What is SKYE’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for SKYE, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is SKYE a Buy, Sell or Hold?
      Currently, no data Available
      What is Skye Bioscience’s price target?
      Currently, no data Available
      What do analysts say about Skye Bioscience?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of SKYE?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.